162 related articles for article (PubMed ID: 38061039)
1. Cost of illness of the vaccine-preventable diseases influenza, herpes zoster and pneumococcal disease in France.
Brown L; Sutton KJ; Browne C; Bartelt-Hofer J; Greiner W; Petitjean A; Roiz J
Eur J Public Health; 2024 Feb; 34(1):170-175. PubMed ID: 38061039
[TBL] [Abstract][Full Text] [Related]
2. Estimated Human and Economic Burden of Four Major Adult Vaccine-Preventable Diseases in the United States, 2013.
McLaughlin JM; McGinnis JJ; Tan L; Mercatante A; Fortuna J
J Prim Prev; 2015 Aug; 36(4):259-73. PubMed ID: 26032932
[TBL] [Abstract][Full Text] [Related]
3. Willingness to get vaccinated against influenza, pneumococcal disease, pertussis, and herpes zoster - A pre-COVID-19 exploration among the older adult population.
Maertzdorf KM; Rietman ML; Lambooij MS; Verschuren WMM; Picavet HSJ
Vaccine; 2023 Feb; 41(6):1254-1264. PubMed ID: 36639273
[TBL] [Abstract][Full Text] [Related]
4. Burden of four vaccine preventable diseases in older adults.
Kristensen M; van Lier A; Eilers R; McDonald SA; Opstelten W; van der Maas N; van der Hoek W; Kretzschmar ME; Nielen MM; de Melker HE
Vaccine; 2016 Feb; 34(7):942-9. PubMed ID: 26752065
[TBL] [Abstract][Full Text] [Related]
5. Determinants of uptake of influenza, zoster and pneumococcal vaccines in patients with cardiovascular diseases.
Benedict Kpozehouen E; Macintyre CR; Tan TC
Vaccine; 2024 May; 42(15):3404-3409. PubMed ID: 38704255
[TBL] [Abstract][Full Text] [Related]
6. Uptake of influenza, pneumococcal and herpes zoster vaccines among people with heart failure and atrial fibrillation.
Kpozehouen EB; Tan T; Macintyre CR
Vaccine; 2022 Dec; 40(52):7709-7713. PubMed ID: 36379753
[TBL] [Abstract][Full Text] [Related]
7. An evaluation of influenza, pneumococcal and herpes zoster vaccination coverage in Australian aged care residents, 2018 to 2022.
Bennett N; Morris B; Malloy MJ; Lim LL; Watson E; Bull A; Sluggett J; Worth LJ;
Infect Dis Health; 2023 Nov; 28(4):253-258. PubMed ID: 37147271
[TBL] [Abstract][Full Text] [Related]
8. Gap between willingness and behavior in the vaccination against influenza, pneumonia, and herpes zoster among Chinese aged 50-69 years.
Lu X; Lu J; Zhang L; Mei K; Guan B; Lu Y
Expert Rev Vaccines; 2021 Sep; 20(9):1147-1152. PubMed ID: 34287096
[TBL] [Abstract][Full Text] [Related]
9. An analysis of factors associated with influenza, pneumoccocal, Tdap, and herpes zoster vaccine uptake in the US adult population and corresponding inter-state variability.
La EM; Trantham L; Kurosky SK; Odom D; Aris E; Hogea C
Hum Vaccin Immunother; 2018 Feb; 14(2):430-441. PubMed ID: 29194019
[TBL] [Abstract][Full Text] [Related]
10. The intention of Dutch general practitioners to offer vaccination against pneumococcal disease, herpes zoster and pertussis to people aged 60 years and older.
Lehmann BA; Eilers R; Mollema L; Ferreira J; de Melker HE
BMC Geriatr; 2017 Jun; 17(1):122. PubMed ID: 28592229
[TBL] [Abstract][Full Text] [Related]
11. Vaccines to Prevent Infectious Diseases in the Older Population: Immunological Challenges and Future Perspectives.
Wagner A; Weinberger B
Front Immunol; 2020; 11():717. PubMed ID: 32391017
[TBL] [Abstract][Full Text] [Related]
12. Impact of influenza, herpes zoster, and pneumococcal vaccinations on the incidence of cardiovascular events in subjects aged over 65 years: a systematic review.
Addario A; Célarier T; Bongue B; Barth N; Gavazzi G; Botelho-Nevers E
Geroscience; 2023 Dec; 45(6):3419-3447. PubMed ID: 37269492
[TBL] [Abstract][Full Text] [Related]
13. Surveillance of Vaccination Coverage Among Adult Populations -United States, 2018.
Lu PJ; Hung MC; Srivastav A; Grohskopf LA; Kobayashi M; Harris AM; Dooling KL; Markowitz LE; Rodriguez-Lainz A; Williams WW
MMWR Surveill Summ; 2021 May; 70(3):1-26. PubMed ID: 33983910
[TBL] [Abstract][Full Text] [Related]
14. Older adults' vaccine hesitancy: Psychosocial factors associated with influenza, pneumococcal, and shingles vaccine uptake.
Nicholls LAB; Gallant AJ; Cogan N; Rasmussen S; Young D; Williams L
Vaccine; 2021 Jun; 39(26):3520-3527. PubMed ID: 34023136
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of routine varicella vaccination using the measles, mumps, rubella and varicella vaccine in France: an economic analysis based on a dynamic transmission model for varicella and herpes zoster.
Littlewood KJ; Ouwens MJ; Sauboin C; Tehard B; Alain S; Denis F
Clin Ther; 2015 Apr; 37(4):830-841.e7. PubMed ID: 25721380
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.
Hornberger J; Robertus K
Ann Intern Med; 2006 Sep; 145(5):317-25. PubMed ID: 16954357
[TBL] [Abstract][Full Text] [Related]
17. Impact of population aging on the burden of vaccine-preventable diseases among older adults in the United States.
Talbird SE; La EM; Carrico J; Poston S; Poirrier JE; DeMartino JK; Hogea CS
Hum Vaccin Immunother; 2021 Feb; 17(2):332-343. PubMed ID: 32758069
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of increasing vaccination in high-risk adults aged 18-64 Years: a model-based decision analysis.
Wateska AR; Nowalk MP; Zimmerman RK; Smith KJ; Lin CJ
BMC Infect Dis; 2018 Jan; 18(1):52. PubMed ID: 29370768
[TBL] [Abstract][Full Text] [Related]
19. A Multifaceted Intervention to Improve Influenza, Pneumococcal, and Herpes Zoster Vaccination among Patients with Rheumatoid Arthritis.
Baker DW; Brown T; Lee JY; Ozanich A; Liss DT; Sandler DS; Ruderman EM
J Rheumatol; 2016 Jun; 43(6):1030-7. PubMed ID: 27084914
[TBL] [Abstract][Full Text] [Related]
20. Costs of adult vaccination in medical settings and pharmacies: an observational study.
Singhal PK; Zhang D
J Manag Care Spec Pharm; 2014 Sep; 20(9):930-6. PubMed ID: 25166292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
